Home
Scholarly Works
Effectiveness of Burosumab Versus Conventional...
Conference

Effectiveness of Burosumab Versus Conventional Therapy in Adults With X-Linked Hypophosphatemia in a Real-World Setting From the XLH Disease Monitoring Program

Authors

Florenzano P; Imel EA; Khan AA; Johnson B; Vincent M; Nomura T; Krolczyk S; Li Z; Ward LM

Volume

39

Pagination

pp. 172-172

Publisher

OXFORD UNIV PRESS

Publication Date

November 1, 2024

Name of conference

Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR)

Conference place

CANADA, Toronto

Conference start date

September 27, 2024

Conference end date

September 30, 2024

Conference proceedings

JOURNAL OF BONE AND MINERAL RESEARCH

ISSN

0884-0431

Contact the Experts team